| Literature DB >> 32747755 |
Sebastian Müller1,2,3, Fabien Sindikubwabo1,2,3, Tatiana Cañeque1,2,3, Anne Lafon1,2,3, Antoine Versini1,2,3, Bérangère Lombard1,2,4, Damarys Loew1,2,4, Ting-Di Wu1,2,5, Christophe Ginestier6,7, Emmanuelle Charafe-Jauffret6,7, Adeline Durand1,2,8, Céline Vallot1,2,8, Sylvain Baulande1,2,9, Nicolas Servant1,10, Raphaël Rodriguez11,12,13.
Abstract
CD44 is a transmembrane glycoprotein linked to various biological processes reliant on epigenetic plasticity, which include development, inflammation, immune responses, wound healing and cancer progression. Although it is often referred to as a cell surface marker, the functional regulatory roles of CD44 remain elusive. Here we report the discovery that CD44 mediates the endocytosis of iron-bound hyaluronates in tumorigenic cell lines, primary cancer cells and tumours. This glycan-mediated iron endocytosis mechanism is enhanced during epithelial-mesenchymal transitions, in which iron operates as a metal catalyst to demethylate repressive histone marks that govern the expression of mesenchymal genes. CD44 itself is transcriptionally regulated by nuclear iron through a positive feedback loop, which is in contrast to the negative regulation of the transferrin receptor by excess iron. Finally, we show that epigenetic plasticity can be altered by interfering with iron homeostasis using small molecules. This study reveals an alternative iron-uptake mechanism that prevails in the mesenchymal state of cells, which illuminates a central role of iron as a rate-limiting regulator of epigenetic plasticity.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32747755 PMCID: PMC7612580 DOI: 10.1038/s41557-020-0513-5
Source DB: PubMed Journal: Nat Chem ISSN: 1755-4330 Impact factor: 24.427